Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
At 5 μM it directly inhibits DUB activity of USP9x
Pilling PA
intrathecally) dose-dependently prevents CFA-induced pain behavior and the associates SGK1 phosphorylation
MLN8237 is currently in Phase II study for treatment of patients with ovarian
Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen
MGCD0103 - CAS# 726169-73-9 Catalog No.:M6555-10 At 5 μM it directlyMGCD0103, also known as Mocetinostat, CAS No. 726169 73 9, is a rationally designed, orally available, Class 1 selective, small molecule, 2 aminobenzamide HDAC inhibitor with potential antineoplastic activity. MGCD0103 binds to and inhibits Class 1 isoforms of HDAC, specifically HDAC 1, 2 and 3, which may result in epigenetic changes in tumor cells and so tumor cell death; although the exact mechanism has yet to be defined, tumor cell death may occur
US$ 397.50
US$ 397.50
US$ 303.00
US$ 397.50
US$ 303.00
US$ 397.50
US$ 397.50
US$ 397.50
US$ 354.98
US$ 397.50
US$ 397.50
US$ 397.50